Novo (NVO) offers injector pen versions of its weight loss therapy semaglutide marketed as Wegovy at $650 for a month’s supply, and the Danish drugmaker doesn’t sell the GLP-1 in vial formats.

The FDA has received reports of dosing errors involving compounded semaglutide injectable products dispensed in multiple-dose ...

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular events by 14% in people with type 2 diabetes and heart or kidney disease. ️ The ...

Trial confirms that oral semaglutide lowers cardiovascular risk in type 2 diabetes, regardless of SGLT2i use. Read more!

Semaglutide increased maximum walking distance by 13% compared with placebo. Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

This growing global health crisis calls for effective obesity treatments to reduce the burden on healthcare systems. Semaglutide, the weekly injectable drug better known by its brand names Ozempic and ...

including semaglutide sodium and semaglutide acetate, so the availability of compounded forms has become controversial. Noom is best known for its eponymous app that helps people become healthier ...

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a ...